MedTrace Logo

Study of the Effect of Telemedicine on Glycemic Control for Patients With Diabetes and Treated With Insulin

NCT04883372 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2021-06-18

No results posted yet for this study

Summary

The purpose of this study is to assess glycemic control changes in insulin-treated patients with diabetes using a continuous glucose monitoring CGM system through the ETAPES telemedicine program.

Conditions

Interventions

OTHER

continuous glucose monitoring

a continuous glucose monitoring CGM system through the ETAPES telemedicine program

Sponsors & Collaborators

  • Centre Hospitalier Sud Francilien

    lead OTHER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-22
Primary Completion
2021-06-08
Completion
2021-06-08

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04883372 on ClinicalTrials.gov